Cannabis Treatment

At Neurology of Cannabis we understand the neurological aspects of treating medical conditions with medical cannabis. Many doctors overlook this very important part of the treatment process. The human brain has naturally occurring binding site receptors that respond to our own internally produced cannabinoid chemicals (endocannabinoids). In the same way the drug Sinemet assists Parkinson’s patients to manage the symptoms of dopamine deficiency, naturally occurring chemical compounds in medical marijuana, called phytocannabinoids, can produce positive treatment results for patients with a deficiency of endocannabinoids. We believe that cannabinoid deficiency is the root cause of a variety of conditions.

Although there are over 100 phytocannabinoids in medical marijuana, the two main compounds are THC and CBD. These compounds, along with the aromatic terpenes, work together, to produce the ‘entourage effect’ or ‘whole plant’ benefit of using cannabis. From studies with synthetic THC and CBD we now know that these molecules work better together (as nature intended) compared with either in isolation.

THC or delta-9-tetrahydrocannabinol is primarily responsible for the psychoactive effects of medical marijuana, also known as a euphoria or ‘high’. THC is also important for many other therapeutic biological effects.

CBD or cannabidiol, also has many biological effects. These include anticonvulsant, anti-inflammatory and antianxiety properties.